Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04282239

Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine if the addition of PECS2 block provides superior post-operative analgesia for cardiac surgery patients after midline sternotomy compared to only standard-of-care post-operative pain medication.

Detailed description

The current study is a prospective, double-blind study investigating the use of pectoral nerves (PECS) block 2 to alleviate post-operative pain in cardiac surgery patients. The investigators anticipate enrolling a total of 220 participants in one of two groups, an interventional PECS block group and a control group not receiving the block. The intervention will occur in the operating room after the completion of the cardiac procedure and prior to the transfer of the participants to the cardiothoracic intensive care unit (CTICU). Both groups will receive the standard-of-care (SOC) pain regimen; the intervention with receive the PECS block in addition to SOC pain regimen. The procedure takes approximately five to ten minutes and will be conducted by the attending cardiac anesthesiologist. Pain will then be monitored hourly in the post-operative period in the CTICU. Additional measures will be investigated that are regularly logged in the electronic medical record.

Conditions

Interventions

TypeNameDescription
PROCEDUREPECS2 blockSuperficial peripheral nerve block placed at the interfascial plane between the pectoralis major and minor muscles and the plane between the pectoralis minor and serrates anterior muscles. Targeted nerves include the lateral and medial pectoral nerves in addition to the long thoracic nerve, thoracodorsal, and thoracic intercostal nerves from T2 to T6.
DRUGRopivacaine 0.5% Injectable Solution15 mL on each side of anterior chest for a total of 30mL
DRUGLidocaine Epinephrine10 mL on each side of anterior chest for a total of 20mL
DRUGDexmedetomidine 0.004 MG/ML10 mL

Timeline

Start date
2021-03-01
Primary completion
2021-12-01
Completion
2022-07-01
First posted
2020-02-24
Last updated
2021-12-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04282239. Inclusion in this directory is not an endorsement.